🔎 Trials Near Me

Akèy › Limfom Difize Gwo Selil B › Colorado › Denver

Etid klinik pou Limfom Difize Gwo Selil B nan Denver, CO

11 etid pou Limfom Difize Gwo Selil B ap chèche patisipan nan sit nan ak bò kote Denver (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)

Ap rekriteFaz 1/2
  • Colorado Blood Cancer Institute ( Site 7000), Denver
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07519772

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

Ap rekriteFaz 1
  • Colorado Blood Cancer Institute, Denver
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07101328

A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

Ap rekriteFaz 1
  • Colorado Blood Cancer Institute, Denver
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07226843

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

Ap rekriteFaz 1/2
  • Colorado Blood Cancer Institute, Denver
Laj 18 ak plis · Tout sèks · Mizajou Aug 25, 2026 · NCT05826535

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

Ap rekriteFaz 1/2
  • Colorado Blood Cancer Institute, Denver
Laj 13 a 90 · Tout sèks · Mizajou Aug 6, 2026 · NCT06533579

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

Ap rekriteFaz 3
  • Colorado Blood Cancer Institute, Denver
Laj 18 ak plis · Tout sèks · Mizajou Aug 4, 2026 · NCT07188558

DALY II USA/ MB-CART2019.1 for DLBCL

Ap rekriteFaz 2
  • Colorado Blood Cancer Institute, Denver
Laj 18 ak plis · Tout sèks · Mizajou Jul 13, 2026 · NCT04792489

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

Ap rekriteFaz 1
  • Colorado Blood Cancer Institute, Denver
Laj 18 ak plis · Tout sèks · Mizajou Jul 2, 2026 · NCT05131022

SynKIR-310 for Relapsed/Refractory B-NHL

Ap rekriteFaz 1
  • Colorado Blood Cancer Institute, part of Sarah Cannon Cancer Institute, Denver
Laj 18 ak plis · Tout sèks · Mizajou Apr 14, 2026 · NCT06544265

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

Ap rekriteFaz 1
  • Sarah Cannon Research Institute at Colorado Blood Cancer Institute, Denver
Laj 18 ak plis · Tout sèks · Mizajou Mar 20, 2026 · NCT04830137

A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies

Ap rekriteFaz 1
  • Colorado Blood Cancer Institute, Denver
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2025 · NCT05780034

Etid Limfom Difize Gwo Selil B nan lòt vil

Lòt etid nan Denver

Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.